Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer.

MLA

Naghibi, Laleh, et al. “Preparation of Nanoliposomes Containing HER2/Neu (P5+435) Peptide and Evaluation of Their Immune Responses and Anti-Tumoral Effects as a Prophylactic Vaccine against Breast Cancer.” PloS One, vol. 15, no. 12, Dec. 2020, p. e0243550. EBSCOhost, https://doi.org/10.1371/journal.pone.0243550.

APA

Naghibi, L., Yazdani, M., Momtazi-Borojeni, A. A., Razazan, A., Shariat, S., Mansourian, M., Arab, A., Barati, N., Arabsalmani, M., Abbasi, A., Saberi, Z., Badiee, A., Jalali, S. A., & Jaafari, M. R. (2020). Preparation of nanoliposomes containing HER2/neu (P5+435) peptide and evaluation of their immune responses and anti-tumoral effects as a prophylactic vaccine against breast cancer. PloS One, 15(12), e0243550. https://doi.org/10.1371/journal.pone.0243550

Chicago

Naghibi, Laleh, Mona Yazdani, Amir Abbas Momtazi-Borojeni, Atefeh Razazan, Sheida Shariat, Mercedeh Mansourian, Atefeh Arab, et al. 2020. “Preparation of Nanoliposomes Containing HER2/Neu (P5+435) Peptide and Evaluation of Their Immune Responses and Anti-Tumoral Effects as a Prophylactic Vaccine against Breast Cancer.” PloS One 15 (12): e0243550. doi:10.1371/journal.pone.0243550.